Ogdol, Shane D.
HRN: 22-62-28 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2026
CEFUROXIME 750MG (VIAL)
05/08/2026
05/15/2026
IV
750mg
Q8
Uti
Checking Initial Appropriateness